Retour
Fourchette du Jour
4,37 €
4,54 €
Fourchette 52 Semaines
1,05 €
6,02 €
Volume
1 694 192
Moyenne 50J / 200J
4,65 €
/
3,96 €
Clôture Précédente
4,40 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,9 | 0,4 |
| P/B | 4,4 | 2,9 |
| ROE % | -68,5 | 3,7 |
| Net Margin % | -1115,3 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
11,13 €
+145.2%
Low: 8,00 €
High: 13,00 €
BPA Prévisionnel
-0,43 €
CA Est.
3,8 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,02 €
1,02 € – 1,02 €
|
920 M | 1 |
| FY2029 |
0,26 €
0,26 € – 0,26 €
|
490 M | 1 |
| FY2028 |
-0,12 €
-0,12 € – -0,12 €
|
200 M | 5 |
Points Clés
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -93,83M
Capital efficient — spends only 7,55% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)17,28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-68,45%
ROIC-31,26%
Net Margin-1115,27%
Op. Margin-1130,65%
Sécurité
Debt / Equity
0,07
Current Ratio12,23
Interest Coverage-1753,94
Valorisation
P/E Ratio
-9,94
P/B Ratio4,39
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,28% | Revenue Growth (3Y) | -20,47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,77M | Net Income (TTM) | -109,00M |
| ROE | -68,45% | ROA | -31,75% |
| Gross Margin | 88,28% | Operating Margin | -1130,65% |
| Net Margin | -1115,27% | Free Cash Flow (TTM) | -93,83M |
| ROIC | -31,26% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 12,23 |
| Interest Coverage | -1753,94 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,94 | P/B Ratio | 4,39 |
| P/S Ratio | 110,81 | PEG Ratio | 2,90 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,08B | Enterprise Value | 781,36M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9,77M | 8,33M | 15,45M | 2,50M | 0,0 |
| Net Income | -109,00M | -89,30M | -111,57M | -166,01M | -174,52M |
| EPS (Diluted) | -0,34 | -0,36 | -0,96 | -3,78 | -4,64 |
| Gross Profit | 8,63M | 8,33M | 15,45M | 14 999,0 | 0,0 |
| Operating Income | -110,50M | -91,46M | -72,44M | -126,03M | -173,27M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 343,32M | 160,36M | 172,73M | 126,28M | 213,96M |
| Total Liabilities | 96,38M | 88,84M | 97,79M | 125,33M | 118,57M |
| Shareholders' Equity | 246,94M | 71,53M | 74,94M | 949 000,0 | 95,38M |
| Total Debt | 18,17M | 63,18M | 61,11M | 59,93M | 63,09M |
| Cash & Equivalents | 319,77M | 139,04M | 143,94M | 87,88M | 149,10M |
| Current Assets | 324,65M | 142,13M | 149,87M | 96,42M | 159,60M |
| Current Liabilities | 26,55M | 26,23M | 36,76M | 62,79M | 51,75M |